Pfizer COVID booster shot for 12 to 15-year-olds backed by USFDA
The regulatory decisions come as COVID cases surge due to the Omicron variant, with health authorities warning that its high transmissibility could overwhelm many health systems.;
New Delhi: The US Food and Drug Administration has authorized the use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children aged between 12 and 15 years, and narrowed the time for all booster shots by a month to five months after the primary doses.
The agency on Monday also authorized a third shot in children aged 5 through 11 years who are immunocompromised.
The regulatory decisions come as COVID-19 cases surge due to the Omicron variant, with health authorities warning that its high transmissibility could overwhelm many health systems.
"Based on the FDA's assessment of currently available data, a booster dose of the currently authorized vaccines may help provide better protection against both the Delta and Omicron variants," said Peter Marks , director of the FDA's Center for Biologics Evaluation and Research.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.